Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

NCT02515097 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: IDP-122 Lotion
DRUG: IDP-122 Vehicle Lotion

Sponsor

Bausch Health Americas, Inc.